A study that compares the safety, efficacy and drug survival of biologics to biosimilars, finds that switching to a biosimilar had no significant impact on drug survival or safe
Dermatology Times – Dermatology
Tag Archives: Biosimilars
A comparison of plaque psoriasis biologics and biosimilars
Switching from originator to biosimilar shows no significant impact on drug survival in plaque psoriasis, but outcomes differ, researchers report.
Dermatology Times – Dermatology
Biosimilars can save billions of healthcare dollars
Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.
Managed Healthcare Executive – Health Management